$BMRN stock analysis (part 1) - price target $120, today's price: $90

Initial look at $BMRN - appears attractive given limited downside regardless of valrox performance. Valrox likely will do well for at least a few years. A next-generation product will be needed. It's unclear competition will do a lot better than valrox, but that's the main risk. Part 2 will be a deeper dive into valrox and refine those estimates.
The model is on my Github:
github.com/mar...